EUVIMEDDescoperă EUVIMED
Crossref

Loxoprofen Lowers Systolic Blood Pressure by Reducing Dietary Sodium Intake in Patients with Type 2 Diabetes

Shuichi Okada, Daiki Shioya, Hiroki Dobashi, Junichi Okada, Kazuya Okada, Eijiro Yamada, Tsugumichi Saito, Kihachi Ohshima, Koji Kikkawa

Clinical Diabetology · 2026-08-03

DOI: 10.5603/cd.113206 ↗

At a glance

Journal article in Clinical Diabetology, published online on 2026-08-03. Written by Shuichi Okada and 8 co-authors.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Cite

APA

Okada, S., Shioya, D., Dobashi, H., Okada, J., Okada, K., Yamada, E., Saito, T., Ohshima, K., & Kikkawa, K. (2026). Loxoprofen Lowers Systolic Blood Pressure by Reducing Dietary Sodium Intake in Patients with Type 2 Diabetes. Clinical Diabetology. https://doi.org/10.5603/cd.113206

Vancouver

Okada S, Shioya D, Dobashi H, Okada J, Okada K, Yamada E, et al. Loxoprofen Lowers Systolic Blood Pressure by Reducing Dietary Sodium Intake in Patients with Type 2 Diabetes. Clinical Diabetology. 2026. doi:10.5603/cd.113206

BibTeX
@article{Okada2026,
  author = {Okada, Shuichi and Shioya, Daiki and Dobashi, Hiroki and Okada, Junichi and Okada, Kazuya and Yamada, Eijiro and Saito, Tsugumichi and Ohshima, Kihachi and Kikkawa, Koji},
  title = {Loxoprofen Lowers Systolic Blood Pressure by Reducing Dietary Sodium Intake in Patients with Type 2 Diabetes},
  journal = {Clinical Diabetology},
  year = {2026},
  doi = {10.5603/cd.113206}
}
Start for free →